Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bayer boosted as FDA OKs its PI3K drug Aliqopa for relapsed follicular lymphoma patients
Bayer boosted as FDA OKs its PI3K drug Aliqopa for relapsed follicular lymphoma patients
Bayer boosted as FDA OKs its PI3K drug Aliqopa for relapsed follicular lymphoma patients
Submitted by
admin
on September 15, 2017 - 9:51am
Source:
Endpoints
News Tags:
Bayer
FDA
Aliqopa
relapsed follicular lymphoma
Headline:
Bayer boosted as FDA OKs its PI3K drug Aliqopa for relapsed follicular lymphoma patients
Do Not Allow Advertisers to Use My Personal information
